CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ:CERS) announced results of 16 abstracts presenting experiences with the INTERCEPT Blood System for platelets, plasma, and red blood ...

Find out what you need to know about a platelet aggregation test, and discover the purpose, results, and risks, and how it may affect health. Skip to main content . Home ; Conditions .

Pall Corporation announced the CE marking of its eBDS System to detect bacterial contamination of red blood cells, the most widely transfused blood component. The Pall eBDS is a highly sensitive ...

Platelet-rich plasma is a form of regenerative medicine. It uses injections of your own blood platelets to help with healing. This treatment hasn’t been approved by the Food and Drug ...

“Given ISBT’s recommendation to transfuse ... the only company in the blood transfusion space to earn both CE Mark and FDA approval for pathogen reduction of both platelet and plasma ...

Researchers discovered that these blood thinners have a negative effect on platelet rich plasma and found a decrease in growth factor content. Their report was published in the American Journal of ...

Cerus Corporation today announced a selection of abstracts and a lunch symposium at the 33 rd Regional International Society of Blood Transfusion Congress, taking place in Gothenburg, Sweden, from ...